Stock ROVI LABORATORIOS FARMACEUTICOS ROVI, S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Laboratorios Farmaceuticos Rovi, S.A. Wiener Boerse

Equities

ROVI

ES0157261019

Real-time Estimate Tradegate
Other stock markets
 10:24:35 03/07/2024 BST 		5-day change 1st Jan Change
85.95 EUR +2.14% Intraday chart for Laboratorios Farmaceuticos Rovi, S.A. +1.02% +38.63%
06-26 Rovi receives non-binding offers for manufacturing business RE
05-08 Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Pharmaceuticals

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
ELI LILLY AND COMPANY Stock Eli Lilly and Company
 816B
NOVO NORDISK A/S Stock Novo Nordisk A/S
 634B
JOHNSON & JOHNSON Stock Johnson & Johnson
 351B - - - -
MERCK & CO., INC. Stock Merck & Co., Inc.
 323B
ABBVIE INC. Stock AbbVie Inc.
 293B
  1. Stock Market
  2. Equities
  3. ROVI Stock
  4. ROVI Stock
  5. Charts Laboratorios Farmaceuticos Rovi, S.A.
  6. Sector Chart